G. Pisano

发表

Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP).

A. Craxì, S. Petta, V. Calvaruso, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans

G. Norata, A. Catapano, S. Fargion, 2017, European journal of preventive cardiology.

High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: Preliminary results.

D. Consonni, S. Fargion, A. Fracanzani, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

An atypical case of typical chest pain

N. Montano, F. Casella, I. Bossi, 2008, Internal and emergency medicine.

Time course of B-type natriuretic peptides changes after ventricular fibrillation: relationships with cardiac syncope.

R. Furlan, G. Casazza, G. Costantino, 2011, International journal of cardiology.

Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin

A. Fracanzani, R. Lombardi, G. Pisano, 2016, International journal of molecular sciences.

Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD

S. Fargion, R. Lombardi, G. Pisano, 2016, International journal of molecular sciences.

NT-pro-BNP for differential diagnosis in patients with syncope.

R. Furlan, G. Costantino, M. Solbiati, 2009, International journal of cardiology.

FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage

L. Rinaldi, C. Acierno, L. Adinolfi, 2020 .

NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes.

E. Orsi, C. Maffeis, G. Targher, 2020, Journal of diabetes and its complications.

Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.

D. Consonni, A. Catapano, S. Fargion, 2016, Atherosclerosis.

The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients

A. Alisi, L. Miele, A. Fracanzani, 2021, Cancers.

Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis

P. Lampertico, S. Fargion, F. Peyvandi, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Unusual presentation in a case of primary hyperparathyroidism

R. Benti, M. Baldini, L. Airaghi, 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

S. Fargion, A. Fracanzani, R. Lombardi, 2021 .

Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study

S. Fargion, A. Fracanzani, M. F. Donato, 2016, World journal of gastroenterology.

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

E. Orsi, C. Maffeis, G. Targher, 2020, Liver international : official journal of the International Association for the Study of the Liver.

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

A. Lupo, F. Scolari, C. Ponticelli, 1998, Journal of the American Society of Nephrology : JASN.

Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice

S. Guzzetti, R. Furlan, N. Montano, 2009, Internal and emergency medicine.

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity

D. Consonni, S. Fargion, A. Craxì, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

ACE and LRPAP1 Insertion-Deletion Polymorphisms in a Northern Ivory Coast Population

M. Ouattara, A. Santovito, P. Cervella, 2007, Human biology.

FibroScan Detects Cardiovascular Damage in Patients With NAFLD.

L. Rinaldi, C. Acierno, L. Adinolfi, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A long story begun with a simple sore throat

S. Fargion, L. Burdick, G. Boccoli, 2010, Internal and emergency medicine.

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease

D. Consonni, G. Norata, A. Catapano, 2016, PloS one.

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population.

G. Norata, K. Garlaschelli, A. Catapano, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Reply to Comment: Is there any place for SGLT2-inhibitors in post-liver transplantation patients?

E. Orsi, A. Fracanzani, D. Dondossola, 2020, Digestive and Liver Disease.

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

L. N. Valenti, S. Fargion, L. Burdick, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.